dry mouth on semaglutide GLP-1 Medications and Mouth: Managing New Side Effects Semaglutide Dry Mouth: Causes, Duration,

(702) 489-3300 Let our team know how we can help with your goals

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that was originally developed for type 2 diabetes management and subsequently approved by the FDA for chronic weight management under the brand name Wegovy

Increases in the dose should be made gradually, in increments of 0.5 mg

Patients taking semaglutide with insulin or sulfonylureas should be particularly vigilant about consistent dosing, as these combinations can increase hypoglycemia risk

By understanding these mechanisms, healthcare providers can better tailor treatments to the specific needs of their patients, thereby improving outcomes in weight management and metabolic health

July 24, 2026 Low Testosterone and Joint Pain: Whats the Connection